65 related articles for article (PubMed ID: 38727313)
1. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.
Simbulan-Rosenthal CM; Islam N; Haribabu Y; Alobaidi R; Shalamzari A; Graham G; Kuo LW; Sykora P; Rosenthal DS
Cells; 2024 May; 13(9):. PubMed ID: 38727313
[TBL] [Abstract][Full Text] [Related]
2. RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis.
Shubhra QTH
Mil Med Res; 2023 Sep; 10(1):42. PubMed ID: 37700352
[No Abstract] [Full Text] [Related]
3. Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination.
Hung YH; Hou YC; Hsu SH; Wang LY; Tsai YL; Shan YS; Su YY; Hung WC; Chen LT
Am J Cancer Res; 2023; 13(8):3417-3432. PubMed ID: 37693128
[TBL] [Abstract][Full Text] [Related]
4. Sema3A alleviates the malignant behaviors of gastric cancer cells by inhibiting NRP-1.
Yang H; Zhou Y; Wang L; Lv M; Sun J; Luo Z; He J
Curr Mol Med; 2023 Aug; ():. PubMed ID: 37533240
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Stem Cells: The Role of CD133.
Yang J; Aljitawi O; Van Veldhuizen P
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358865
[TBL] [Abstract][Full Text] [Related]
6. Nuclear AREG affects a low-proliferative phenotype and contributes to drug resistance of melanoma.
Seefried F; Haller L; Fukuda S; Thongmao A; Schneider N; Utikal J; Higashiyama S; Bosserhoff AK; Kuphal S
Int J Cancer; 2022 Dec; 151(12):2244-2264. PubMed ID: 36054710
[TBL] [Abstract][Full Text] [Related]
7. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.
Arnold M; Singh D; Laversanne M; Vignat J; Vaccarella S; Meheus F; Cust AE; de Vries E; Whiteman DC; Bray F
JAMA Dermatol; 2022 May; 158(5):495-503. PubMed ID: 35353115
[TBL] [Abstract][Full Text] [Related]
8. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells.
Simbulan-Rosenthal CM; Haribabu Y; Vakili S; Kuo LW; Clark H; Dougherty R; Alobaidi R; Carney B; Sykora P; Rosenthal DS
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216449
[TBL] [Abstract][Full Text] [Related]
9. Hallmarks of Cancer: New Dimensions.
Hanahan D
Cancer Discov; 2022 Jan; 12(1):31-46. PubMed ID: 35022204
[TBL] [Abstract][Full Text] [Related]
10. CD133 Act as an Essential Marker in Ovarian Carcinogenesis.
Ikram D; Masadah R; Nelwan BJ; Zainuddin AA; Ghaznawie M; Wahid S
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3525-3531. PubMed ID: 34837909
[TBL] [Abstract][Full Text] [Related]
11. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
12. Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer.
Sun Q; Yu X; Peng C; Liu N; Chen W; Xu H; Wei H; Fang K; Dong Z; Fu C; Xu Y; Lu W
Biomed Pharmacother; 2020 Aug; 128():110274. PubMed ID: 32464305
[TBL] [Abstract][Full Text] [Related]
13. ERK/MAPK signalling pathway and tumorigenesis.
Guo YJ; Pan WW; Liu SB; Shen ZF; Xu Y; Hu LL
Exp Ther Med; 2020 Mar; 19(3):1997-2007. PubMed ID: 32104259
[TBL] [Abstract][Full Text] [Related]
14. The Communication Between the PI3K/AKT/mTOR Pathway and Y-box Binding Protein-1 in Gynecological Cancer.
Sobočan M; Bračič S; Knez J; Takač I; Haybaeck J
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947591
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis.
Simbulan-Rosenthal CM; Dougherty R; Vakili S; Ferraro AM; Kuo LW; Alobaidi R; Aljehane L; Gaur A; Sykora P; Glasgow E; Agarwal S; Rosenthal DS
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623313
[TBL] [Abstract][Full Text] [Related]
16. Current Perspectives in Cancer Immunotherapy.
Christofi T; Baritaki S; Falzone L; Libra M; Zaravinos A
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31575023
[TBL] [Abstract][Full Text] [Related]
17. CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition.
Simbulan-Rosenthal CM; Gaur A; Zhou H; AbdusSamad M; Qin Q; Dougherty R; Aljehane L; Kuo LW; Vakili S; Karna K; Clark H; McCarron E; Rosenthal DS
J Oncol; 2019; 2019():6486173. PubMed ID: 31379943
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
Morrison J; Thoma C; Goodall RJ; Lyons TJ; Gaitskell K; Wiggans AJ; Bryant A
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007927. PubMed ID: 30321910
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
